Form 4: Teva Pharmaceutical Industries EVP, CFO Eliyahu Sharon Kalif Reports Share Disposal
SEC Form 4 Filing
Eliyahu Sharon Kalif, EVP and CFO of Teva Pharmaceutical Industries, reported the disposal of 18,430 ordinary shares on February 28, 2024, following the vesting of restricted share units.
Summary
- On February 28, 2024, Eliyahu Sharon Kalif, the EVP and Chief Financial Officer of Teva Pharmaceutical Industries, disposed of 18,430 ordinary shares.
- This transaction occurred due to the vesting of restricted share units granted on February 28, 2020.
- Following the transaction, Kalif directly owns 124,222 ordinary shares.
- The restricted share units were granted on February 28, 2020, and vested in four equal installments on February 28 of 2021, 2022, 2023, and 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting a routine transaction related to executive compensation. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive share transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. This transaction represents the vesting of previously granted equity compensation.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in beneficial ownership of company shares.
Key Dates
| Date | Description |
|---|---|
| 02/28/2020 | Restricted share units were granted. |
| 02/28/2021 | First vesting date of restricted share units (18,430 shares). |
| 02/28/2022 | Second vesting date of restricted share units (18,430 shares). |
| 02/28/2023 | Third vesting date of restricted share units (18,430 shares). |
| 02/28/2024 | Fourth vesting date of restricted share units (18,430 shares) and date of reported transaction. |
| 03/01/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.